AzTrials
AzTrials

Alternative Method of Apnea TestAPNEE REANCT01911286

Comparison of Two Strategies to Realize Apnea Test for the Diagnostic of Brain in Potentiel Organ Donors.

An observational study of Alternative Method of Apnea Test, run by Poitiers University Hospital at 17 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Clinical diagnostic of brain death requires a non-reactive coma, absence of brain stem reflex, and absence of spontaneous breathing. The confirmation of absence of spontaneous breathing is established the apnea test (according to the American Academy of Neurology's Guidelines). Read more about this study

Who is it for?
Ages 18 to 75 years
Conditions the study is for
Alternative Method of Apnea Test
What is being tested?
Apnea test - Standard and Apnea test - CPAP
Type of treatment
Surgery or procedure
How many people
208 participants
Where
17 sitesFrance
Study dates
Jul 2013to Dec 2015
How long will I take part?
1 Day
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Potentiel organs donors in brain death.

Who may be able to join

  • Age : from 18 to 75 years
  • Neurological signs evoking cerebral ischemia

Who cannot join

  • Severe hypoxemia (PaO2/FiO2 < 200) with controlled ventilation (FiO2: 100%)
  • Hypothermia < 36°C
  • Obesity (BMI ≥ 40) with documented hypopnoea
  • Intractable hypotension despite optimal filling and catecholamine doses > 1µg.Kg.min
  • Patients with contraindication for organs harvesting.
  • Documented chronic respiratory failure
  • Progressive infectious acute respiratory disease
  • Family opposition to subject's participation in the study

Trial locations and contacts

17 sites in 1 country.

17 sites in 1 country

France17 sites
  • Angers University Hospital

    Angers, 49933

  • Angoulême Hospital

    Angoulême, 16959

  • Bordeaux University Hospital

    Bordeaux, 33076

  • Brest University Hospital

    Brest, 29200

  • Tours University Hospital

    Chambray-lès-Tours, 37170

  • Sud Francilien Hospital

    Corbeil-Essonnes, 91106

  • La Roche sur Yon Hospital

    La Roche-sur-Yon, 85925

  • La Rochelle Hospital

    La Rochelle, 17019

  • Limoges University Hospital

    Limoges, 87042

  • Nantes University Hospital

    Nantes, 44093

  • Nice University Hospital

    Nice, 06006

  • Orléans Hospital

    Orléans, 45067

  • Cochin University Hospital

    Paris, 75679

  • Poitiers University Hospital

    Poitiers, 86000

  • Rennes University hospital

    Rennes, 35033

  • Saintes Hospital

    Saintes, 17108

  • Toulon University Hospital

    Toulon, 83056

Other trials in France

About this study

Clinical diagnostic of brain death requires a non-reactive coma, absence of brain stem reflex, and absence of spontaneous breathing. The confirmation of absence of spontaneous breathing is established the apnea test (according to the American Academy of Neurology's Guidelines). However this test may lead to complications (acute hypoxemia, ventilatory and cardiocirculatory disorders) and reduces significantly the number of lung transplants. Some data suggest modifying the apnea test : replace the ventilator switching off with continuous positive airway pressure (CPAP) use. These studies showed that this alternative method (CPAP) increased the level of lung harvest but they were not sufficient because these studies were monocentric with little patients,. That why the aim of the present study is to compare the standard strategy and CPAP strategy with a prospective, multicenter,cluster trial; each center will use the method of apnea test which it uses usually.

Being tested
Apnea test - Standard, Apnea test - CPAP

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Apnea test - StandardProcedure or surgery

  • Apnea test - CPAPProcedure or surgery

Study groups in NCT01911286
Study groupRoleWhat they receive
Standard groupApnea test according to the recommendation
Receives: Procedure: Apnea test - Standard
CPAP groupApnea test with CPAP connection
Receives: Procedure: Apnea test - CPAP

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Eligibility to lung harvest

    Measured: 2 years

Secondary outcomes (6)
  1. Levels of hypoxemia

    Measured: 2 years

  2. Arterial blood gas after apnea test

    Measured: 2 years

  3. Rate of ventilatory impairment

    Measured: 2 years

  4. Rate of cardiocirculatory impairment

    Measured: 2 years

  5. Rate of apnea test interruption

    Measured: 2 years

  6. Number of lung transplantation realization

    Measured: 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Jul 2013 (estimated)
  2. Study startJul 2013
  3. Primary completionDec 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
208 participants (actual)
Target duration
1 Day
IDs, dates and publications
ClinicalTrials.gov ID
NCT01911286
Sponsor's protocol ID
APNEE REA
Acronym
APNEE REA
Status last verified
Oct 2016
First submitted
26 Jul 2013
Last updated
11 Oct 2016
Results posted
No

Questions about this trial

What is this clinical trial studying?

An observational study of Alternative Method of Apnea Test, run by Poitiers University Hospital at 17 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Oct 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 17 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Eligibility to lung harvest (time frame: 2 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Oct 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in